Aperçu rapide pour Moloney Sarcoma Oncogene (MOS) (Middle Region) Peptide (ABIN980193)
Antigène
MOS
(Moloney Sarcoma Oncogene (MOS))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
Protein Region
Middle Region
Attributs du produit
This is a synthetic peptide designed for use in combination with anti-MOS antibody (Catalog #: ARP56631_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
MOS
(Moloney Sarcoma Oncogene (MOS))
Sujet
MOS is a serine/threonine kinase that activates the MAP kinase cascade through direct phosphorylation of the MAP kinase activator MEK (MAP2K1, MIM 176872) (Prasad et al., 2008 [PubMed 18246541]).
Alias Symbols: MGC119962, MGC119963, MSV
Protein Interaction Partner: BMPR2,HSPA1A,MYOD1,MYOD1